Key result
Defective vascular and myeloid cell autophagy drives atherosclerosis progression across key vascular cell types.
Answers are grounded in this paper and cite their sources.
Atherosclerosis is a chronic inflammatory disease of the arterial vessel wall and underlies the development of cardiovascular diseases, such as myocardial infarction and ischemic stroke. As such, atherosclerosis stands as the leading cause of death and disability worldwide and intensive scientific efforts are made to investigate its complex pathophysiology, which involves the deregulation of crucial intracellular pathways and intricate interactions between diverse cell types. A growing body of evidence, including in vitro and in vivo studies involving cell-specific deletion of autophagy-related genes (ATGs), has unveiled the mechanistic relevance of cell-specific (endothelial, smooth-muscle, and myeloid cells) defective autophagy in the processes of atherogenesis. In this review, we underscore the recent insights on autophagy's cell-type-dependent role in atherosclerosis development and progression, featuring the relevance of canonical catabolic functions and emerging noncanonical mechanisms, and highlighting the potential therapeutic implications for prevention and treatment of atherosclerosis and its complications.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2021) conducted a review in Atherosclerosis. Cell-specific defective autophagy was evaluated. Cell-specific defective autophagy in endothelial, smooth-muscle, and myeloid cells plays a mechanistic role in the development and progression of atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: